Grace Cancer Foundation IPO 2026: Issue Details, Subscription Status and Social Stock Exchange Listing

Grace Cancer Foundation IPO 2026: Latest Update

Grace Cancer Foundation, a Hyderabad-based non-profit organisation, has entered India's Social Stock Exchange ecosystem to raise funds for cancer screening, early detection and community healthcare programmes.

Unlike a conventional IPO, this offering is a Zero Coupon Zero Principal (ZCZP) issue. It is designed to mobilise funding for social causes rather than provide investors with equity ownership or financial returns.

The proposed issue size is ₹1 crore, with a minimum application amount of ₹1,000. The issue was announced for October 2026. Published platforms show differing closing dates, with some listing October 9 and others showing an extended window through October 21. Contributors should verify the current status on the official NSE Social Stock Exchange platform before applying.

Grace Cancer Foundation IPO Details

The ZCZP instrument is a social-financing mechanism. It should not be confused with an equity share offering, and its ₹10 denomination does not represent a conventional stock market price.

Grace Cancer Foundation IPO Subscription Status

Subscription information published by IPO-tracking platforms has shown limited reported demand, but the figures and closing dates vary across sources. A reliable final subscription figure should be confirmed against the exchange's official issue records.

Since the issue may have reached or passed its reported closing date, prospective contributors should first check whether applications are still being accepted. A historical subscription figure does not establish that the issue remains open.

What Is a ZCZP Issue?

A Zero Coupon Zero Principal instrument allows eligible non-profit organisations to raise funds through the Social Stock Exchange. Contributors do not receive interest payments or repayment of their principal, unlike conventional bonds or deposits.

The instrument is intended to support the organisation's stated social objectives. Reporting and disclosures help explain how funds are used and what outcomes are achieved.

Therefore, contributors should evaluate the intended social impact, the organisation's governance and its reporting commitments rather than assess the offering using conventional IPO indicators such as listing gains, earnings per share or grey market premium.

About Grace Cancer Foundation

Grace Cancer Foundation, also known as GRACE — Global Research and Cancer Education, is a charitable organisation established in Hyderabad in 2013 by medical professionals.

Its work focuses on cancer prevention, awareness, early detection and assistance for people who face barriers to healthcare. The foundation uses community outreach, medical camps and mobile screening initiatives to reach people who may have limited access to diagnostic services.

Its broader programmes also include patient navigation support, healthcare research and technology-assisted screening initiatives.

Objectives of Grace Cancer Foundation IPO

The funds raised through the ZCZP issue are intended to expand the foundation's cancer screening and early-detection programmes.

Key areas of focus include:

• Cancer screening: Supporting community-level screening activities and early identification of potential health concerns.

• Mobile screening initiatives: Extending screening services to underserved and remote communities.

• Cancer awareness: Educating people about risk factors, warning signs and the importance of timely medical consultation.

• Early detection: Helping individuals identified through screening access appropriate diagnostic and treatment services.

The intended benefit is social rather than financial. Contributors should review the issue documents for the specific programme targets and the reporting arrangements associated with the funds raised.

Grace Cancer Foundation IPO GMP Today

There is no conventional equity IPO grey market premium (GMP) to report for this issue. GMP is commonly discussed for equity shares expected to trade on a stock exchange, whereas Grace Cancer Foundation's ZCZP issue is designed for social-impact funding.

Consequently, an estimated listing price or percentage listing gain is not applicable. Contributors should focus on the organisation's objectives, the terms of the instrument and its impact disclosures.

Important Points Before Contributing

Before submitting an application, consider these points:

• The contribution does not provide equity ownership in Grace Cancer Foundation.

• The instrument carries no interest payment and no principal repayment.

• It should not be treated as a short-term investment for listing profits.

• Review the issue's fund-utilisation plan and social-impact reporting commitments.

• Confirm the current issue status and application process through the official exchange platform.

Any tax benefit should be verified against the applicable rules and the contributor's circumstances; it should not be assumed solely from the instrument's ZCZP classification.

Grace Cancer Foundation IPO Summary

Grace Cancer Foundation's ₹1 crore ZCZP issue is intended to mobilise funds for cancer screening, awareness and early-detection programmes. The minimum application amount is ₹1,000, and the instrument is fundamentally different from a conventional equity IPO because it offers neither ownership nor financial repayment.

The issue's reported closing dates differ across available platforms, so its current status should be checked before applying. For anyone considering a contribution, the most important factors are the foundation's social objectives, transparent use of funds and measurable healthcare outcomes.